Table II.

Burkitt lymphoma incidence for three age groups of cases diagnosed during 1978–2002 and reported to the

	Age Group, years
	0–19			25–49					55–84
Region	N	Rate	95% CI		N	Rate	95% CI		N	Rate	95% CI		HIV Prevalence (%)
All Regions	1372	1.57	1.48	1.65	829	0.79	0.73	0.84	817	1.45	1.34	1.55
East Asia	42	0.64	0.44	0.83	10	0.10	0.04	0.16	28	0.48	0.30	0.66	0.10
Canada	268	1.82	1.60	2.04	200	1.02	0.88	1.17	216	2.07	1.78	2.35	0.15
Western and Central Europe	684	2.11	1.95	2.27	425	1.04	0.94	1.13	384	1.38	1.23	1.52	0.30
South and Southeast Asia	114	0.59	0.48	0.7	36	0.19	0.13	0.25	33	0.73	0.47	0.98	0.30
Australia	161	1.92	1.62	2.22	125	1.16	0.96	1.36	139	2.33	1.92	2.73	0.38
Latin America	103	1.78	1.44	2.13	33	0.65	0.42	0.87	17	1.28	0.64	1.92	0.60

International Agency for Research on Cancer

Rate per million person-years, age-adjusted (world standard population); HIV prevalence based on UNAIDS estimates for 2008; age groups 20–24 years and 50–54 years were excluded.